Affluent Medical SA (EPA:AFME)
1.330
+0.030 (2.31%)
May 12, 2025, 5:36 PM CET
Affluent Medical Statistics
Total Valuation
EPA:AFME has a market cap or net worth of EUR 52.33 million. The enterprise value is 68.92 million.
Market Cap | 52.33M |
Enterprise Value | 68.92M |
Important Dates
The last earnings date was Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EPA:AFME has 39.35 million shares outstanding.
Current Share Class | 39.35M |
Shares Outstanding | 39.35M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | 0.17% |
Float | 5.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 9.78 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.68 |
EV / Sales | 12.88 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -60.49 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 81,061 |
Profits Per Employee | -223,318 |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.57% in the last 52 weeks. The beta is 0.62, so EPA:AFME's price volatility has been lower than the market average.
Beta (5Y) | 0.62 |
52-Week Price Change | -25.57% |
50-Day Moving Average | 1.36 |
200-Day Moving Average | 1.57 |
Relative Strength Index (RSI) | 44.53 |
Average Volume (20 Days) | 2,012 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:AFME had revenue of EUR 5.35 million and -14.74 million in losses.
Revenue | 5.35M |
Gross Profit | 2.09M |
Operating Income | -14.64M |
Pretax Income | -14.88M |
Net Income | -14.74M |
EBITDA | -12.24M |
EBIT | -14.64M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | n/a |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | -11.32M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 39.03%, with operating and profit margins of -273.63% and -275.50%.
Gross Margin | 39.03% |
Operating Margin | -273.63% |
Pretax Margin | -278.15% |
Profit Margin | -275.50% |
EBITDA Margin | -228.84% |
EBIT Margin | -273.63% |
FCF Margin | n/a |
Dividends & Yields
EPA:AFME does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -28.16% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |